University of Maryland School of Medicine review reveals a rise in cannabis-related psychiatric conditions

The increased use and potency of cannabis are linked to a rise in cannabis-related psychiatric conditions, according to a review article from the University of Maryland School of Medicine. The article stresses the need for doctors to screen and treat patients experiencing symptoms of cannabis use disorder, which means users are experiencing significant problems from their use of the drug.

Cannabis use disorder is defined as problematic marijuana use and symptoms include craving the drug and failing to control use despite experiencing negative side effects like problems at work or school. It typically presents in people who use cannabis more than four days a week. Primary risk factors are frequency and duration of use, another substance use disorder, or another psychiatric condition. Physical symptoms range from yellowing of fingertips to increased depression and anxiety while using cannabis.

According to the American Psychiatric Association, nearly one in five Americans ages 12 and older used cannabis in 2021, with more than 16 million meeting the criteria for cannabis use disorder. Young adults aged 18 to 25 are disproportionately affected, with over 14 percent in this age group having cannabis use disorder. The review highlights the importance of recognizing signs and symptoms for proper diagnosis and treatment.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Related Posts

Spelling error report

The following text will be sent to our editors: